Search Our Research

Developing New Immunotherapies for Triple-Negative Breast Cancer

A diagnosis of triple-negative breast cancer (TNBC) means that the tumour lacks the three most commo ...
Read more...

Strengthening the Immune System to Fight Breast Cancer Tumours

In the past decade, one of the most exciting advances in the treatment of cancer has been the develo ...
Read more...

New Therapies to Outsmart Treatment Resistance in Aggressive Breast Cancer

Drug therapy is an important part of primary treatment for breast cancer and is the treatment of cho ...
Read more...

Reawakening the “Guardian of the Genome” to Fight Drug Resistance

A new class of drug called CDK4/6 inhibitors are poised to become the standard of care for the treat ...
Read more...

Identifying and Targeting the ‘Seeds’ of Metastatic Breast Cancer

Despite improved health outcomes for people with triple negative breast cancer (TNBC) over the last ...
Read more...

Validation of a Novel Target that Inhibits Breast Cancer Metastasis

Metastatic breast cancer is breast cancer that has spread to another part of the body. Most commonly ...
Read more...

Liquid Biopsies for Monitoring and Managing Breast Cancer

Currently, the diagnosis of breast cancer and treatment monitoring often requires invasive tissue b ...
Read more...

Mapping the Cell Atlas of Breast Cancer

Breast cancers are a complex ‘ecosystem’ of many cell types. These cell interactions play a cent ...
Read more...

THE KATHLEEN CUNINGHAM FOUNDATION CONSORTIUM FOR RESEARCH INTO FAMILIAL BREAST CANCER (kConFab)

Breast cancer will affect one in eight Australian women and touch the lives of many families. For ab ...
Read more...

BRAVEHeart – empowering breast cancer radiotherapy patients to save their hearts

More than 15,000 women in Australia were diagnosed with breast cancer in 2015. For more than 13,000 ...
Read more...